Approvals/TGA/APO-Tenofovir/Emtricitabine 300/200 tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack

Approved

STANDARD

APO-Tenofovir/Emtricitabine 300/200 tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1aa0690fea4ef8af
Product Name: APO-Tenofovir/Emtricitabine 300/200 tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack
Artg Id: 275068
Artg Name: APO-Tenofovir/Emtricitabine 300/200 tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2017-11-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

1aa0690fea4ef8af

Type

Standard